Alzamend Neuro Inc Stock Ownership - Who owns Alzamend Neuro?

Insider buying vs selling

Have Alzamend Neuro Inc insiders been buying or selling?
Milton C. Ault IiiDirector2024-04-191,000$0.69
Milton C. Ault IiiDirector2024-04-01334$0.91
Milton C. Ault IiiDirector2024-01-055,000$1.02
Milton C. Ault IiiDirector2024-01-052,000$1.06
Lynne Fahey McGrathDirector2023-12-26666$0.88
Milton C. Ault Iii10% Owner2023-12-26500$0.90
Milton C. Ault Iii10% Owner2023-12-22200$0.92
David J. KatzoffChief Financial Officer2023-09-2653,000$0.19

1 of 1

ALZN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALZN insiders and whales buy or sell their stock.

ALZN Shareholders

What type of owners hold Alzamend Neuro Inc stock?
Milton C. Ault Iii5,377.42%36,925,942$140.69MInsider
William B. Horne145.63%1,000,000$3.81MInsider
Truist Financial Corp22.47%154,327$587.99kInstitution
Jeffrey Oram14.56%100,000$381.00kInsider
Andrew H. Woo14.56%100,000$381.00kInsider
David J. Katzoff11.80%81,000$308.61kInsider
Vanguard Group Inc11.44%78,545$299.26kInstitution
Mark Gustafson8.74%60,000$228.60kInsider
Geode Capital Management LLC7.63%52,397$199.63kInstitution
Stephan Jackman6.63%45,500$173.36kInsider

1 of 3

ALZN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALZN1.00%99.00%Net Buying
ENTO0.71%99.29%Net SellingNet Selling
QNRX0.02%99.98%Net SellingNet Selling
ADTX0.36%99.64%Net Selling

Alzamend Neuro Stock Ownership FAQ

Who owns Alzamend Neuro?

Alzamend Neuro (NASDAQ: ALZN) is owned by 56.37% institutional shareholders, 5,580.06% Alzamend Neuro insiders, and 0.00% retail investors. Milton C. Ault Iii is the largest individual Alzamend Neuro shareholder, owning 36.93M shares representing 5,377.42% of the company. Milton C. Ault Iii's Alzamend Neuro shares are currently valued at $137.36M.

If you're new to stock investing, here's how to buy Alzamend Neuro stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.